Skip to main content

New Myeloma Drug FDA Approved

The FDA just approved Pomalidomid, Pomalyst, for treatment of multiple myeloma in patients who have previously been treated with lenalidomide and bortezomib based therapy.

Author
Dr. Ashkan Lashkari

You Might Also Enjoy...